B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide

被引：14

作者：

Fuerstenau, Moritz ^{[1
]}

Fink, Anna Maria ^{[1
]}

Schilhabel, Anke ^{[2
]}

Weiss, Jonathan ^{[1
]}

Robrecht, Sandra ^{[1
]}

Eckert, Robert ^{[3
]}

de la Serna, Javier ^{[4
]}

Crespo, Marta ^{[5
,6
]}

Coscia, Marta ^{[7
,8
]}

Vitale, Candida ^{[7
,8
]}

Boettcher, Sebastian ^{[2
,9
]}

Weppner, Gesche ^{[2
]}

Ritgen, Matthias ^{[2
]}

Stilgenbauer, Stephan ^{[10
,11
]}

Tausch, Eugen ^{[10
]}

Fischer, Kirsten ^{[1
]}

Hallek, Michael ^{[1
,12
]}

Eichhorst, Barbara ^{[1
]}

Brueggemann, Monika ^{[2
]}

Herling, Carmen D. ^{[1
]}

机构：

[1] Univ Cologne, Univ Hosp Cologne, Dept Internal Med 1, German CLL Study Grp,Ctr Integrated Oncol Aachen, Cologne, Germany

[2] Univ Schleswig Holstein, Dept Internal Med 2, Campus Kiel, Kiel, Germany

[3] Onkol Schwerpunktpraxis Esslingen, Esslingen, Germany

[4] Hosp Univ 12 Octubre, Serv Hematol, Madrid, Spain

[5] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Barcelona, Spain

[6] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain

[7] Azienda Osped Univ Citta Salute & Sci Torino, Univ Div Hematol, Turin, Italy

[8] Univ Torino, Dept Mol Biotechnol & Hlth Sci, Turin, Italy

[9] Rostock Univ, Med Ctr, Med Clin Hematol Oncol & Palliat Med 3, Rostock, Germany

[10] Univ Ulm, Dept Internal Med 3, Ulm, Germany

[11] Saarland Univ, Dept Internal Med 1, Sch Med, Homburg, Germany

[12] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany

来源：

BLOOD | 2021年 / 137卷 / 16期

关键词：

2ND PRIMARY MALIGNANCIES; 1ST-LINE TREATMENT; OPEN-LABEL; CYCLOPHOSPHAMIDE; FLUDARABINE; RITUXIMAB; THERAPY; IKZF1; TRANSFORMATION; BENDAMUSTINE;

D O I：

10.1182/blood.2020008609

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2267 / 2271

页数：5

共 25 条

[1] Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myeloma [J].

Aldoss, Ibrahim ;

Capelletti, Marzia ;

Park, Jihye ;

Pistofidis, Romanos Sklavenitis ;

Pillai, Raju ;

Stiller, Tracey ;

Sanchez, James F. ;

Forman, Stephen J. ;

Ghobrial, Irene M. ;

Krishnan, Amrita .

LEUKEMIA, 2019, 33 (01) :266-270

[2] Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study [J].

Brueggemann, Monika ;

Kotrova, Michaela ;

Knecht, Henrik ;

Bartram, Jack ;

Boudjogrha, Myriam ;

Bystry, Vojtech ;

Fazio, Grazia ;

Fronkova, Eva ;

Giraud, Mathieu ;

Grioni, Andrea ;

Hancock, Jeremy ;

Herrmann, Dietrich ;

Jimenez, Cristina ;

Krejci, Adam ;

Moppett, John ;

Reigl, Tomas ;

Salson, Mikael ;

Scheijen, Blanca ;

Schwarz, Martin ;

Songia, Simona ;

Svaton, Michael ;

van Dongen, Jacques J. M. ;

Villarese, Patrick ;

Wakeman, Stephanie ;

Wright, Gary ;

Cazzaniga, Giovanni ;

Davi, Frederic ;

Garcia-Sanz, Ramon ;

Gonzalez, David ;

Groenen, Patricia J. T. A. ;

Hummel, Michael ;

Macintyre, Elizabeth A. ;

Stamatopoulos, Kostas ;

Pott, Christiane ;

Trka, Jan ;

Darzentas, Nikos ;

Langerak, Anton W. .

LEUKEMIA, 2019, 33 (09) :2241-2253

[3]

Chakhachiro Z, 2017, HEMATOL ONCOL, V35, P130

[4] Metabolic gatekeeper function of B-lymphoid transcription factors [J].

Chan, Lai N. ;

Chen, Zhengshan ;

Braas, Daniel ;

Lee, Jae-Woong ;

Xiao, Gang ;

Geng, Huimin ;

Cosgun, Kadriye Nehir ;

Hurtz, Christian ;

Shojaee, Seyedmehdi ;

Cazzaniga, Valeria ;

Schjerven, Hilde ;

Ernst, Thomas ;

Hochhaus, Andreas ;

Kornblau, Steven M. ;

Konopleva, Marina ;

Pufall, Miles A. . ;

Cazzaniga, Giovanni ;

Liu, Grace J. ;

Milne, Thomas A. ;

Koeffler, H. Phillip ;

Ross, Theodora S. ;

Sanchez-Garcia, Isidro ;

Borkhardt, Arndt ;

Yamamoto, Keith R. ;

Dickins, Ross A. ;

Graeber, Thomas G. ;

Mueschen, Markus .

NATURE, 2017, 542 (7642) :479-+

[5] Acquired Initiating Mutations in Early Hematopoietic Cells of CLL Patients [J].

Damm, Frederik ;

Mylonas, Elena ;

Cosson, Adrien ;

Yoshida, Kenichi ;

Della Valle, Veronique ;

Mouly, Enguerran ;

Diop, M'boyba ;

Scourzic, Laurianne ;

Shiraishi, Yuichi ;

Chiba, Kenichi ;

Tanaka, Hiroko ;

Miyano, Satoru ;

Kikushige, Yoshikane ;

Davi, Frederick ;

Lambert, Jerome ;

Gautheret, Daniel ;

Merle-Beral, Helene ;

Sutton, Laurent ;

Dessen, Philippe ;

Solary, Eric ;

Akashi, Koichi ;

Vainchenker, William ;

Mercher, Thomas ;

Droin, Nathalie ;

Ogawa, Seishi ;

Nguyen-Khac, Florence ;

Bernard, Olivier A. .

CANCER DISCOVERY, 2014, 4 (09) :1088-1101

[6] Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial [J].

Edelmann, J. ;

Tausch, E. ;

Landau, D. A. ;

Robrecht, S. ;

Bahlo, J. ;

Fischer, K. ;

Fink, A. M. ;

Bloehdorn, J. ;

Holzmann, K. ;

Boettcher, S. ;

Werner, L. ;

Kneba, M. ;

Gribben, J. G. ;

Neuberg, D. S. ;

Wu, C. J. ;

Hallek, M. ;

Doehner, H. ;

Stilgenbauer, S. .

LEUKEMIA, 2017, 31 (03) :734-738

[7] First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial [J].

Eichhorst, Barbara ;

Fink, Anna-Maria ;

Bahlo, Jasmin ;

Busch, Raymonde ;

Kovacs, Gabor ;

Maurer, Christian ;

Lange, Elisabeth ;

Koeppler, Hubert ;

Kiehl, Michael ;

Soekler, Martin ;

Schlag, Rudolf ;

Vehling-Kaiser, Ursula ;

Koechling, Georg ;

Ploeger, Christoph ;

Gregor, Michael ;

Plesner, Torben ;

Trneny, Marek ;

Fischer, Kirsten ;

Doehner, Harmut ;

Kneba, Michael ;

Wendtner, Clemens-Martin ;

Klapper, Wolfram ;

Kreuzer, Karl-Anton ;

Stilgenbauer, Stephan ;

Boettcher, Sebastian ;

Hallek, Michael .

LANCET ONCOLOGY, 2016, 17 (07) :928-942

[8] Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia [J].

Eichhorst, BF ;

Busch, R ;

Hopfinger, G ;

Pasold, R ;

Hensel, M ;

Steinbrecher, C ;

Siehl, S ;

Jäger, U ;

Bergmann, M ;

Stilgenbauer, S ;

Schweighofer, C ;

Wendtner, CM ;

Döhner, H ;

Brittinger, G ;

Emmerich, B ;

Hallek, M .

BLOOD, 2006, 107 (03) :885-891

[9] Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets.: Report of the BIOMED-2 Concerted Action BHM4-CT98-3936 [J].

Evans, P. A. S. ;

Pott, Ch ;

Groenen, P. J. T. A. ;

Salles, G. ;

Davi, F. ;

Berger, F. ;

Garcia, J. F. ;

van Krieken, J. H. J. M. ;

Pals, S. ;

Kluin, Ph ;

Schuuring, E. ;

Spaargaren, M. ;

Boone, E. ;

Gonzalez, D. ;

Martinez, B. ;

Villuendas, R. ;

Gameiro, P. ;

Diss, T. C. ;

Mills, K. ;

Morgan, G. J. ;

Carter, G. I. ;

Milner, B. J. ;

Pearson, D. ;

Hummel, M. ;

Jung, W. ;

Ott, M. ;

Canioni, D. ;

Beldjord, K. ;

Bastard, C. ;

Delfau-Larue, M. H. ;

van Dongen, J. J. M. ;

Molina, T. J. ;

Cabecadas, J. .

LEUKEMIA, 2007, 21 (02) :207-214

[10] IMiDs prime myeloma cells for daratumumab-mediated cytotoxicity through loss of Ikaros and Aiolos [J].

Fedele, Pasquale L. ;

Willis, Simon N. ;

Liao, Yang ;

Low, Michael S. ;

Rautela, Jai ;

Segal, David H. ;

Gong, Jia-Nan ;

Huntington, Nicholas D. ;

Shi, Wei ;

Huang, David C. S. ;

Grigoriadis, George ;

Tellier, Julie ;

Nutt, Stephen L. .

BLOOD, 2018, 132 (20) :2166-2178

← 1 2 3 →